ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Pittsburgh, PA, USA:

New

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight (SELENE 2)

The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to pl...

Not yet enrolling
Diabetes Mellitus, Type 2
Obesity or Overweight
Drug: AZD6234
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Scottdale, Pennsylvania, United States and 217 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Uniontown, Pennsylvania, United States and 89 other locations

in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...

Begins enrollment this month
Diabetes Mellitus, Type 2
Drug: Orforglipron
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Smithfield, Pennsylvania, United States of America and 70 other locations

The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to pl...

Not yet enrolling
With/Without Diabetes Mellitus, Type 2
Weight-Related Comorbidity
Drug: AZD6234
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Smithfield, Pennsylvania, United States and 87 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Active, not recruiting
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Pittsburgh, Pennsylvania, United States and 78 other locations

Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term effic...

Enrolling
Type 2 Diabetes Mellitus
Overweight
Drug: ASC30 tablets A1
Drug: Placebo

Phase 3

Ascletis Pharma (China) Co., Limited

Pittsburgh, Pennsylvania, United States and 135 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Pittsburgh, Pennsylvania, United States and 29 other locations

The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....

Active, not recruiting
Type 1 Diabetes
Drug: VX-264

Phase 1, Phase 2

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 15 other locations

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling
Diabetic Foot Ulcer
Device: COMS One device
Device: Sham device
Piomic Medical

McKeesport, Pennsylvania, United States and 28 other locations

The purpose of this study is to assess the safety and efficacy of SkinTE for treatment of Wagner grade 1 diabetic foot ulcers....

Active, not recruiting
Diabetic Foot
Biological: SkinTE
Other: Control

Phase 3

PolarityTE

East Liverpool, Ohio, United States and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems